| Serial Number | 88676989 |
| Word Mark | GALVUS |
| Filing Date | Friday, November 1, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 29, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 3, 2020 |
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma |
| Translation of Words in Mark | The wording "GALVUS" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 5, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Basel 4002 CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Basel 4002 CH |
| Event Date | Event Description |
| Tuesday, May 30, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, May 29, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, October 18, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 17, 2022 | SOU EXTENSION 5 GRANTED |
| Thursday, October 6, 2022 | SOU EXTENSION 5 FILED |
| Monday, October 17, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, October 6, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 27, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 25, 2022 | SOU EXTENSION 4 GRANTED |
| Monday, April 25, 2022 | SOU EXTENSION 4 FILED |
| Monday, April 25, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 26, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, October 23, 2021 | SOU EXTENSION 3 GRANTED |
| Saturday, October 23, 2021 | SOU EXTENSION 3 FILED |
| Saturday, October 23, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 27, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 23, 2021 | SOU EXTENSION 2 GRANTED |
| Friday, April 23, 2021 | SOU EXTENSION 2 FILED |
| Friday, April 23, 2021 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 28, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 26, 2020 | SOU EXTENSION 1 GRANTED |
| Monday, October 26, 2020 | SOU EXTENSION 1 FILED |
| Monday, October 26, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 28, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 3, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 12, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, January 30, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 30, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 30, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 30, 2020 | ASSIGNED TO LIE |
| Monday, January 27, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 15, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 15, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 15, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, January 3, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, November 5, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 5, 2019 | NEW APPLICATION ENTERED |